Ramsay Health Care Limited share price up 2% on global supply chain JV

The Ramsay Health Care Limited (ASX:RHC) share price is up 2% after announcing it is setting up a global supply chain joint venture.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ramsay Health Care Limited (ASX: RHC) share price is up 2% after announcing that it is entering into a global supply chain joint venture.

Its partner is called Ascension, the largest private, tax-exempt, non-governmental health organisation in the United States.

Ramsay said that the joint venture will combine the purchasing power of the St. Louis-based Ascension, the world's largest Catholic health system and Ramsay Health Care. Of course, readers will know Ramsay as one of the world's largest private hospital operators that operates over 230 facilities in six countries across four continents.

The joint venture company will be owned equally by Ramsay and Ascension. It will start by identifying an initial group of product categories to achieve procurement savings.

Ramsay also said that in time it will include more product categories and will explore broader business development opportunities that are expected to generate further commercial benefits for the two entities.

This new joint venture will apparently be undertaken with minimal cost to each group and the initial savings will be slightly earnings per share (EPS) accretive to Ramsay in the short-term.

Foolish takeaway

Ramsay didn't flag this as a material announcement. To start off with, it won't be – but it could turn into something quite material if it develops into a major player for product procurement, particularly in the huge US market.

I like Ramsay as an investment idea due to the quality of the business and long-term ageing of the population. This doesn't change its figures much in the near future, but at 20x FY19's estimated earnings I think it represents attractive long-term value.

Motley Fool contributor Tristan Harrison owns shares of Ramsay Health Care Limited. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

3 ASX healthcare shares surging on big news

The ASX healthcare sector is higher on Tuesday and these stocks are among the strongest performers.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

The pros and cons of buying CSL shares right now

It’s an interesting time to consider this healthcare giant.

Read more »

Vanadium Resources share price person riding rocket indicating share price increase
Healthcare Shares

Why did this ASX biotech stock explode 52% higher on Monday?

Shareholders of this stock were smiling today. What happened?

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why is everyone talking about ResMed shares?

It’s been a good year for ResMed shareholders. Let’s find out why.

Read more »

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

This bombshell for ASX healthcare shares could hit 6 million Australians

This could have a large impact.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

2 ASX healthcare shares having a stellar run today

The ASX healthcare sector is down today but these two stocks are bucking the trend.

Read more »

A company manager presents the ASX company earnings report to shareholders at an AGM.
Healthcare Shares

Why this $13 billion ASX 200 healthcare stock is surging today

A change in sentiment for the healthcare player.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

This ASX 200 stock hit a 52-week low and a top broker thinks it can rebound

Patient investors may see this stock make a pleasing recovery.

Read more »